AcelRx Pharmaceuticals (ACRX) soars on defense contract

AcelRx Pharmaceuticals Inc

shares gained 10.3% to $3.32 after the company reported that it has been awarded a contract worth up to $17 million from the Department of Defense to advance ARX-04. Share volume totaled 233,000, compared to an all-day average of 172,000